CYNOSURE INC 4

4 · CYNOSURE INC · Filed Apr 19, 2016

Form 4

Period: 2016-04-15

Executive VP, CFO, Treasurer

Transactions

Exercise/Conversion
Class A Common Stock
2016-04-15$30.51/sh+4,075$124,328→ 4,075 total
Sale
Class A Common Stock
2016-04-18$45.04/sh−8$360→ 0 total
Sale
Class A Common Stock
2016-04-15$45.02/sh−4,075$183,439→ 0 total
Exercise/Conversion
Employee Stock Option (right to buy)
2016-04-15−9,925→ 23,334 total
Exercise: $29.40Exp: 2024-02-13→ Class A Common Stock (9,925 underlying)
Exercise/Conversion
Class A Common Stock
2016-04-15$29.40/sh+9,925$291,795→ 9,925 total
Sale
Class A Common Stock
2016-04-15$45.02/sh−9,925$446,781→ 0 total
Exercise/Conversion
Class A Common Stock
2016-04-18$30.51/sh+8$244→ 8 total
Exercise/Conversion
Employee Stock Option (right to buy)
2016-04-15−4,075→ 16,342 total
Exercise: $30.51Exp: 2025-02-11→ Class A Common Stock (4,075 underlying)
Exercise/Conversion
Employee Stock Option (right to buy)
2016-04-18−8→ 16,334 total
Exercise: $30.51Exp: 2025-02-11→ Class A Common Stock (8 underlying)

Footnotes (5)

[F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
[F2]The sales price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $45.00 to $45.08 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
[F3]The sales price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $45.00 to $45.04 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
[F4]The option became exercisable as to approximately 8.33% of the shares on each three-month anniversary of the 2/13/2014 grant date.
[F5]The option became exercisable as to approximately 8.33% of the shares on each three-month anniversary of the 2/11/2015 grant date.

Documents

1 file